|
Volumn 9, Issue 4 PART 2, 2009, Pages 932-941
|
Heart transplantation in the United States, 1998-2007
|
Author keywords
Graft survival; Heart transplantation; OPTN; Patient survival; SRTR
|
Indexed keywords
ANTIMETABOLITE;
BASILIXIMAB;
CALCINEURIN;
CYCLOSPORIN;
DACLIZUMAB;
EVEROLIMUS;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
RAPAMYCIN;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ARTIFICIAL VENTILATION;
DONOR SELECTION;
GRAFT RECIPIENT;
GRAFT SURVIVAL;
HEALTH CARE POLICY;
HEART FAILURE;
HEART TRANSPLANTATION;
HOSPITAL ADMISSION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
MORTALITY;
PATIENT CARE;
PRIORITY JOURNAL;
REVIEW;
UNITED STATES;
FEMALE;
HEART FAILURE;
HEART TRANSPLANTATION;
HUMANS;
MALE;
MIDDLE AGED;
PATIENT SELECTION;
REGISTRIES;
SURVIVAL RATE;
SURVIVORS;
TIME FACTORS;
UNITED STATES;
WAITING LISTS;
|
EID: 63449094043
PISSN: 16006135
EISSN: 16006143
Source Type: Journal
DOI: 10.1111/j.1600-6143.2009.02568.x Document Type: Review |
Times cited : (40)
|
References (6)
|